๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Liver Cirrhosis
Clinical trial register · China

Liver Cirrhosis Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Chongqing 4 Xi'an 3 Hangzhou 3 Beijing 3 Qingdao 3
Narrow the registerReset
Recruitment status
Phase
Site location
Chongqing4 Xi'an3 Hangzhou3 Beijing3 Qingdao3
All 24 locations
Target enrolment
to

Liver Cirrhosis trials in China

23 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction
NCT07252401Liver Cirrhosis
General Hospital of Shenyang Military Region
Not applicable
64
Shenyang
2026-09-25
Recruiting
Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
NCT07799948Hepatic Encephalopathy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Portal Hypertension, Liver Cirrhosis
Air Force Military Medical University, China
Not applicable
30
Xi'an
2026-09-01
Not yet open
Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis
NCT07830303Liver Cirrhosis, Sleep Disturbance, Hepatic Encephalopathy
Wang Fengmei
Phase 4
180
Tianjin
2026-09
Recruiting
Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
NCT07811687Liver Cirrhosis, HCC - Hepatocellular Carcinoma, Hypersplenism
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-08-02
Not yet open
Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis
NCT07587671Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices
West China Hospital
Not applicable
240
Chengdu, Chongqing, Xiamen
2026-08-01
Not yet open
A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy
NCT07612670Hepatic Encephalopathy, Minimal Hepatic Encephalopathy, Liver Cirrhosis
The First Affiliated Hospital with Nanjing Medical University
Observational
700
Nanjing
2026-08-01
Not yet open
Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism
NCT07490405Liver Cirrhosis
Northern Jiangsu People's Hospital
Observational
140
Yangzhou
2026-06-01
Not yet open
Sonazoid CEUS for Early HCC Surveillance
NCT07590284Liver Cirrhosis, Liver Fibrosis
Tianjin Third Central Hospital
Not applicable
556
Tianjin
2026-05-30
By invitation
Pantoprazole After Prophylactic Endoscopic Variceal Treatment
NCT07248722Esophageal and Gastric Varices, Liver Cirrhosis
General Hospital of Shenyang Military Region
Not applicable
208
Shenyang
2026-03-27
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Not yet open
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
NCT07350070HCC, Liver Cirrhosis, Portal Hypertension
DrugTACE
Tongji Hospital
Phase 2
78
Fuzhou, Nanning, Taihe, Wuhan, Jinan, Qingdao
2025-12-31
Recruiting
Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NCT07252102Liver Cirrhosis, Polyps of Colon, Gastrointestinal Dysfunction
Zhejiang University
Not applicable
450
Shenzhen, Hangzhou
2025-11-20
Recruiting
Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis
NCT07253389Liver Cirrhosis, Gastroesophageal Varices Bleeding
Air Force Military Medical University, China
Not applicable
648
Xi'an
2025-10-20
Recruiting
The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
NCT07151885Liver Cirrhosis, Esophageal and Gastric Varices
The First Hospital of Jilin University
Not applicable
380
Changchun
2025-08-31
Recruiting
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NCT07116096Liver Cirrhosis, Portal Hypertension
Shanxi Provincial People's Hospital
Not applicable
120
Luoyang, Taiyuan
2025-08-17
Recruiting
Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis
NCT07271576Liver Fibrosis, Liver Cirrhosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-06-04
Recruiting
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
NCT07053488Liver Diseases, Liver Cancer, Liver Cirrhosis, Liver Failure
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2
90
Beijing
2025-06-01
Active, closed
Spirulina Tablets Treat Liver Fibrosis/Cirrhosis
NCT06770283Liver Cirrhosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2024-12-26
Recruiting
Underdilated-stent Technique Improves Post-TIPS Encephalopathy
NCT07349654Liver Cirrhosis, Variceal Bleeding, Cirrhosis, Ascites Hepatic, Hepatic Encephalopathy (HE)
The Second Affiliated Hospital of Chongqing Medical University
Not applicable
72
Chongqing, Qianjiang
2024-11-19
Recruiting
Digital Early Warning System for Acute Lung Injury in Liver Surgery
NCT07070362Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human, MASLD
Beijing Tsinghua Chang Gung Hospital
Observational
3,000
Beijing, Chongqing, Qingdao
2024-11-01
Active, closed
Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
NCT07437638Liver Cirrhosis, Hepatic Encephalopathy, TIPS
The Second Affiliated Hospital of Chongqing Medical University
Observational
624
Chongqing
2024-09-01
Active, closed
A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis
NCT05979935Esophageal Varices, Liver Cirrhosis, Sublingual Varices, Portal Hypertension
Qilu Hospital of Shandong University
Observational
1,300
Jinan
2023-07-01
Active, closed
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT
NCT05513651Liver Cirrhosis, Malnutrition
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2016-07-01
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/liver-cirrhosis

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies listing the condition Liver Cirrhosis.

How many Liver Cirrhosis trials are recruiting in China?

10 of the 23 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 8 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Liver Cirrhosis), 23 studies
PhaseStudiesRecruitingShare
Not applicable12752.2%
Observational8234.8%
Phase 1/2114.3%
Phase 2104.3%
Phase 4104.3%

Most active sponsors

Lead sponsors with the most studies (Liver Cirrhosis)
Lead sponsorStudiesRecruiting
Air Force Military Medical University, China22
General Hospital of Shenyang Military Region20
Northern Jiangsu People's Hospital21
Second Affiliated Hospital, Zhejiang University, School of Medicine21
The Second Affiliated Hospital of Chongqing Medical University21
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC11
Beijing Tsinghua Chang Gung Hospital11
First Affiliated Hospital Xi'an Jiaotong University10
Peking University First Hospital10
Qilu Hospital of Shandong University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.